Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
|
By LabMedica International staff writers Posted on 01 Aug 2018 |

Image: One model from the new series of TSG compact refrigerators (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) showcased innovations for research and clinical labs and also launched a new series of compact refrigerators at the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo held July 29 – August 2 in Chicago, USA.
At AACC 2018, Thermo Fisher displayed its range of LC-MS instruments, including the fully automated Cascadion SM Clinical Analyzer, Prelude LX-4 MD HPLC, and Endura MD Mass Spectrometer. Thermo Fisher’s lab solutions portfolio showcased at this year’s AACC included the recently CE-marked Phadia 200 instrument which requires less than six square feet of lab space and can run up to 700 different ImmunoCAP and EliA quantitative tests, including the recently cleared peanut allergen component ImmunoCAP Ara h6. Thermo Fisher also showcased its new B·R·A·H·M·S KRYPTOR GOLD immunoassay analyzer, which features increased capacity and has been developed for optimal automation, efficiency and precision.
Thermo Fisher showcased its Ion Torrent Oncomine solutions, including the Oncomine Dx Target Test, the first FDA-approved companion diagnostic for non-small cell lung cancer. The company also demonstrated its Ion GeneStudio S5 Prime system, as well as other oncology research assays designed for studies in blood-based cancers, liquid biopsy, childhood cancers and immuno-oncology. In addition, Thermo Fisher featured new compounds for antimicrobial susceptibility testing: delafloxacin and meropenem/vaborbactam. Also on display at the event were the recently announced Thermo Scientific B·R·A·H·M·S PCT direct point-of-care assay for procalcitonin (PCT) measurement in acute care settings and its novel range of ChromaCare flush solutions and ultrapure solvents for ultrahigh-performance LC-MS systems.
"Clinical customers and translational researchers demand analytical platforms that support higher throughput, accuracy and scalability," said Patrick Durbin, senior vice president and president of specialty diagnostics for Thermo Fisher Scientific. "The common goal is actionable data that's delivered with confidence, and we're highlighting our portfolio of leading products at AACC to support their needs, from research to the clinic."
At this year’s AACC, Thermo Fisher launched the new series of TSG compact refrigerators for clinical laboratories and patient care facilities requiring secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, all in a quiet unit with a small footprint. The new refrigerators have been designed to provide uninterrupted temperature stability and cleanroom-compatible readiness for reliable materials storage. They operate at a sound level of less than 35 dbA and have ENERGY STAR-rated performance, consuming significantly less energy than similar models to meet increasing demands for sustainability and reduced operating costs.
"Maintaining optimal cold storage conditions is of utmost importance in clinical settings to preserve the viability of stored materials, as is the need to maximize efficiencies by locating vaccines, medicines and lab kits close to their point of use," said Alex Esmon, senior product manager, cold storage, laboratory equipment, Thermo Fisher Scientific. "With this in mind, we have introduced the new series of high-performing refrigerators to offer our clinical customers confidence that their valuable materials are fully protected at all times. The solid state technology used in the TSG Series allows for minimal impact on the clinical environment through reduced operational noise and heat output, while the systems' small size maximizes working space."
At AACC 2018, Thermo Fisher displayed its range of LC-MS instruments, including the fully automated Cascadion SM Clinical Analyzer, Prelude LX-4 MD HPLC, and Endura MD Mass Spectrometer. Thermo Fisher’s lab solutions portfolio showcased at this year’s AACC included the recently CE-marked Phadia 200 instrument which requires less than six square feet of lab space and can run up to 700 different ImmunoCAP and EliA quantitative tests, including the recently cleared peanut allergen component ImmunoCAP Ara h6. Thermo Fisher also showcased its new B·R·A·H·M·S KRYPTOR GOLD immunoassay analyzer, which features increased capacity and has been developed for optimal automation, efficiency and precision.
Thermo Fisher showcased its Ion Torrent Oncomine solutions, including the Oncomine Dx Target Test, the first FDA-approved companion diagnostic for non-small cell lung cancer. The company also demonstrated its Ion GeneStudio S5 Prime system, as well as other oncology research assays designed for studies in blood-based cancers, liquid biopsy, childhood cancers and immuno-oncology. In addition, Thermo Fisher featured new compounds for antimicrobial susceptibility testing: delafloxacin and meropenem/vaborbactam. Also on display at the event were the recently announced Thermo Scientific B·R·A·H·M·S PCT direct point-of-care assay for procalcitonin (PCT) measurement in acute care settings and its novel range of ChromaCare flush solutions and ultrapure solvents for ultrahigh-performance LC-MS systems.
"Clinical customers and translational researchers demand analytical platforms that support higher throughput, accuracy and scalability," said Patrick Durbin, senior vice president and president of specialty diagnostics for Thermo Fisher Scientific. "The common goal is actionable data that's delivered with confidence, and we're highlighting our portfolio of leading products at AACC to support their needs, from research to the clinic."
At this year’s AACC, Thermo Fisher launched the new series of TSG compact refrigerators for clinical laboratories and patient care facilities requiring secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, all in a quiet unit with a small footprint. The new refrigerators have been designed to provide uninterrupted temperature stability and cleanroom-compatible readiness for reliable materials storage. They operate at a sound level of less than 35 dbA and have ENERGY STAR-rated performance, consuming significantly less energy than similar models to meet increasing demands for sustainability and reduced operating costs.
"Maintaining optimal cold storage conditions is of utmost importance in clinical settings to preserve the viability of stored materials, as is the need to maximize efficiencies by locating vaccines, medicines and lab kits close to their point of use," said Alex Esmon, senior product manager, cold storage, laboratory equipment, Thermo Fisher Scientific. "With this in mind, we have introduced the new series of high-performing refrigerators to offer our clinical customers confidence that their valuable materials are fully protected at all times. The solid state technology used in the TSG Series allows for minimal impact on the clinical environment through reduced operational noise and heat output, while the systems' small size maximizes working space."
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
- Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








